Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05537103 · ClinicalTrials.gov registry record
Adolescents Seeking COVID Vaccination (Teen COVID Vax)
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 454
- Enrollment target
NCT05537103: Completed study, sponsored by National Institutes of Health Clinical Center (CC).
NCT05537103 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 454 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05537103 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 454 participants
- Enrollment target
Study Summary
Background: Information is limited on the experience of children aged 15 to 17 who have or have not been vaccinated against COVID-19. Research has assessed attitudes toward COVID-19 vaccination among adults and parents of teenagers. Few surveys have explored attitudes among teens themselves. Objective: This anonymous cross-sectional survey of a national sample US teens to find out about their experiences and attitudes on getting vaccinated for COVID-19. This study will be conducted in collaboration with a national firm (Qualtrics) responsible for the recruitment and data collection. Eligibility: People aged 15 to 17 years. Participants will come from urban, suburban, and rural areas in the United States. Factors such as race and gender will match US averages. Participants will only include subjects recruited by Qualtrics from their national panel of available respondents, who have agreed to be contacted by Qualtrics with opportunities to participate in surveys. Design: Participants will be contacted by email. The email will include a link to the survey. The emails will be sent only to people who agreed to be contacted about taking surveys. Participants will complete the survey online. It should take only 10 minutes. Questions will include the following: Have participants been vaccinated against COVID-19? Are they in the process of getting vaccinated? Do they want to be vaccinated? Have they had trouble getting vaccinated? If so, what kind of barriers did they face? What reasons have they considered for and against getting vaccinated? What have their personal experiences been with COVID-19? What is their primary source of information about COVID-19? Other questions will ask about: Household size. Employment of people in the household. How many people in the house have been vaccinated. The primary language spoken at home. The natural history survey will be anonymous. Participants will not be asked to give their names....
Primary Outcome
We will be asking 15-17 year olds if they encountered barriers when accessing COVID vaccination. Our primary outcome will be the number and types of barriers encountered.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 454 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2023-07-12 |
What the finished NCT05537103 record still lists
NCT05537103 is an observational study that tracks outcomes without assigning an intervention. The registered 454 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05537103 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05537103 about?
NCT05537103 is a clinical study titled "Adolescents Seeking COVID Vaccination (Teen COVID Vax)". Background: Information is limited on the experience of children aged 15 to 17 who have or have not been vaccinated against COVID-19. Research has assessed attitudes toward COVID-19 vaccination among adults and parents of teenagers. Few surveys have explored attitudes among teens themselves. Objec...
What is the current status of trial NCT05537103?
This trial is currently completed. The enrollment target is 454 participants. The study started on 2022-09-26. Estimated completion is 2023-07-12.
Who is sponsoring clinical trial NCT05537103?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT05655936 · 454 participants · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
- NCT06510374 · 454 participants · Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
- NCT06935357 · 454 participants · Phase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI